MPS-LOC

MPS-LOC ReadyCell
ReadyCell Communications Department
21 February 2024
ProgrammeProyectos de I+D+i en Líneas Estratégicas 2022 (MICIN)
Budget79.541 Euros
Duration2022-2025 (36 months)
ConsortiumLeitat (project coordinator), Vall d’Hebron Institut de Recerca, ReadyCell

The primary goal of this project, MPS-LOC “Microphysiological systems based on liver-on-chip for drug discovery and testing”, is to develop liver-on-chip systems that integrate microfluidics, 3D printing, human-derived liver cells, and liver-derived bioinks. These systems aim to replace animal models in drug discovery, offering higher predictive value in preclinical drug development.

These liver-on-chip devices are expected to represent human liver physiology and function more accurately for drug discovery, and their adaptability to include multi-donor pooling could provide data that better reflects the diverse metabolisms found in the population.

More projects

3DLIVER

3DLIVER

Readycell is leading the coordination of the 3DLIVER project, which is dedicated to creating innovative in vitro models from human liver tissue.

SEGURAM

SEGURAM

Readycell’s expertise in in vitro permeability assays with Caco-2 cells has allowed the development of novel gut-on-a-chip model in Seguram.

BIOPRINTIA

BIOPRINTIA

ReadyCell collaborates in the BioPrintIA project as a specialized partner in the biotechnology sector.